Read + Share
Amedeo Smart
Independent Medical Education
Raschi E, Squizzato A. Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation. N Engl J Med 2025;392:1556-1557.PMID: 40239082
Email
LinkedIn
Privacy Policy